ScholarIQanswers from OpenAlex & ORCID
Zhengfei Zhu
ResearcherPublications, citations & collaboration network
Zhengfei Zhu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Zhengfei Zhu have?
ScholarIQindexed works
Zhengfei Zhu has 209 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Zhengfei Zhu have?
ScholarIQcitation count
Zhengfei Zhu has 3,666 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Zhengfei Zhu?
ScholarIQh-index
Zhengfei Zhu has an h-index of 31 in OpenAlex.
What is the i10-index of Zhengfei Zhu?
ScholarIQi10-index
Zhengfei Zhu has an i10-index of 77 in OpenAlex.
What is the ORCID of Zhengfei Zhu?
ScholarIQorcid
The ORCID for Zhengfei Zhu is on the source record.
What is the OpenAlex record for Zhengfei Zhu?
ScholarIQopenalex
The OpenAlex for Zhengfei Zhu is on the source record.
What are the most-cited papers on Zhengfei Zhu?
ScholarIQmost cited works
Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer
Xiaomei Gong, Xuefei Li, Tao Jiang, Huikang Xie, Zhengfei Zhu, Fei Zhou, Caicun Zhou
MicroRNA 23b Regulates Autophagy Associated With Radioresistance of Pancreatic Cancer Cells
Peng Wang, Juan Zhang, Li Zhang, Zhengfei Zhu, Jie Fan, Lianyu Chen, Liping Zhuang, Jian‐Min Luo, Hao Chen, Luming Liu, Zhen Chen, Zhiqiang Meng
Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells
Xi Yang, Yida Li, Liqing Zou, Zhengfei Zhu
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial
Yun Chen, Jinjun Ye, Zhengfei Zhu, Weixin Zhao, Jialiang Zhou, Chaoyang Wu, Huarong Tang, Min Fan, Ling Li, Qin Lin, Yi Xia, Yunhai Li, Jiancheng Li, Huixun Jia, Saiquan Lu, Zhen Zhang, Kuaile Zhao
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort
Written on behalf of AME Lung Cancer Collaborative Group, Yong Song, Chengping Hu, Zhanhong Xie, Lin Wu, Zhengfei Zhu, Chuangzhou Rao, Li Liu, Yuan Chen, Naixin Liang, Jun Chen, Chunhong Hu, Nong Yang, Jie Hu, Weixin Zhao, Gangling Tong, Xiaorong Dong, Di Zheng, Meiling Jin, Jianhua Chen, Meijuan Huang, Yong He, Rafael Rosell, Giuseppe Lippi, Mari Mino–Kenudson, Han Han‐Zhang, Xinru Mao, Lu Zhang, Hao Liu, John K. Field, Shannon Chuai, Junyi Ye, Yusheng Han, Shun Lü